Terms: = Uterine cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Clinical Outcome
2 results:
1. Loss of expression of smarca4 (brg1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
Kuo KT; Liang CW; Hsiao CH; Lin CH; Chen CA; Sheu BC; Lin MC
Mod Pathol; 2006 Dec; 19(12):1570-7. PubMed ID: 16998464
[TBL] [Abstract] [Full Text] [Related]
